ChristianSutterHinrichsMD

Assistant Clinical Investigator

Dr. Hinrichs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2014
George Washington UniversityResidency, Internal Medicine, 2009 - 2010
University of Missouri Kansas City School of MedicineClass of 1996

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols Start of enrollment: 2016 Apr 11
Recruiting
E7 TCR T Cells for Human Papillomavirus-Associated Cancers Start of enrollment: 2017 Jan 27
Recruiting
Phase 1, Phase 2
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers Start of enrollment: 2024 Jun 12
Not yet recruiting
Phase 1, Phase 2
Roles: Sponsor-Investigator, Contact, Principal Investigator

PubMed

409 citations
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8 + T cells via TLR4 signaling
Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser, Christian S. Hinrichs, Marcello Chieppa
The Journal of Clinical Investigation. 2007-08-01
1262 citations
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
Eric Tran, Simon Turcotte, Alena Gros, Paul F. Robbins, Yong-Chen Lu
Science. 2014-05-09
103 citations
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity.
Douglas C. Palmer, Chi-Chao Chan, Luca Gattinoni, Claudia Wrzesinski, Chrystal M. Paulos
Proceedings of the National Academy of Sciences of the United States of America. 2008-06-10

The Next Generation of Treatments for Advanced Cervical CancerAugust 27th, 2021
Anuzis: U.S. Drug Industry Saving Lives – if Congress Doesn’t Squelch ItJune 4th, 2021
Research Leader Named to Rutgers Cancer Institute from National Cancer Institute to Build World-Class Cancer Immunology and Immunotherapy ProgramsJanuary 11th, 2021
Join now to see all